Signant Health and Lothar Medical Sign Letter of Intent to Commercialize ALDS PRO for Clinical Trials

<p>Collaboration creates a path to combine Signant's market-leading eCOA and digital endpoint capabilities with Lothar Medical's three-in-one ALDS PRO respiratory assessment system PHILADELPHIA, and WÜRZBURG, Germany, Sept. 5, 2026 /PRNewswire/ -- Signant Health, a leading provider of...</p>